Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Cantor Fitzgerald
US Department of Justice
Cerilliant
McKinsey
Harvard Business School
Accenture
Mallinckrodt
Argus Health

Generated: June 22, 2018

DrugPatentWatch Database Preview

AEROBID Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Aerobid patents expire, and what generic alternatives are available?

Aerobid is a drug marketed by Roche Palo and is included in one NDA.

The generic ingredient in AEROBID is flunisolide. There are twelve drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the flunisolide profile page.
Drug patent expirations by year for AEROBID
Synonyms for AEROBID
(1S,2S,4R,8S,9S,11S,12S,13R,19S)-19-fluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.0;{2,9}.0;{4,8}.0;{13,18}]icosa-14,17-dien-16-one
(1S,2S,4R,8S,9S,11S,12S,13R,19S)-19-FLUORO-11-HYDROXY-8-(2-HYDROXYACETYL)-6,6,9,13-TETRAMETHYL-5,7-DIOXAPENTACYCLO[10.8.0.0(2),?.0?,?.0(1)(3),(1)?]ICOSA-14,17-DIEN-16-ONE
(6a,11b,16a)-6-Fluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-pregna-1,4-diene-3,20-dione
32277-EP2281815A1
32277-EP2295402A2
32277-EP2301933A1
32277-EP2305640A2
32277-EP2308562A2
32277-EP2311827A1
32277-EP2371811A2
3385-03-3
385F033
6 alpha-fluoro-11 beta,16 alpha,17,21- tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16, 17-acetal with acetone
6 alpha-fluorodihydroxy-16 alpha,17 alpha-isopropylidenedioxy-1,4-pregnadiene-3,20- dione
6-Fluoro-11,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 16,17-acetonide
6-Fluoro-11,21-dihydroxy-16,17-(isopropylidenedioxy)pregna-1,4-diene-3,20-dione
6alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16, 17-acetal with acetone
77326-96-6
78M02AA8KF
AB1010905
ABP000528
AC-3514
AC1L32UV
Aerobid M
Aerospan
AKOS025402038
AN-12914
BCP9000696
BPBio1_000711
BRD-K49577446-001-03-1
Bronalide
BSPBio_000645
C07005
CAS-3385-03-3
CCG-220643
CHEBI:5106
CHEMBL1512
CS-4713
DB00180
DSSTox_CID_25534
DSSTox_GSID_45534
DSSTox_RID_80936
DTXSID1045534
EINECS 222-193-2
Flunie
Flunisolida
Flunisolida [INN-Spanish]
flunisolide
Flunisolide (anhydrous)
Flunisolide [anhydrous]
Flunisolide [INN]
Flunisolide Hemihydrate
Flunisolide HFA
Flunisolide(Nasalide)/
Flunisolidum
Flunisolidum [INN-Latin]
GTPL7076
HMS1570A07
HMS2097A07
HMS2236A06
HMS3259L10
HY-B1121
LS-118464
Lunis
lunisolide anhydrous
MFCD00133324
MLS002153928
MolPort-005-943-434
Nasalide
Nasarel
NC00716
NCGC00016983-01
NCGC00179492-01
NCGC00179492-03
Nisolid
PL000385
Pregna-1,4-diene-3,20-dione, 6-alpha-fluoro-11-beta,16-alpha,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone
Pregna-1,4-diene-3,20-dione, 6-fluoro-11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-, (6alpha,11beta,16alpha)-
Prestwick_223
Prestwick0_000643
Prestwick1_000643
Prestwick2_000643
Prestwick3_000643
Q834
Rhinalar
RS 3999
RS-3999
SCHEMBL4351
SMR001233272
Soluzione
SPBio_002566
Synaclyn
Syntaris
Tox21_110725
Tox21_110725_1
UNII-78M02AA8KF
ZINC4097305

US Patents and Regulatory Information for AEROBID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche Palo AEROBID flunisolide AEROSOL, METERED;INHALATION 018340-001 Aug 17, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Citi
Merck
Fuji
Julphar
Chinese Patent Office
Medtronic
Farmers Insurance
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.